BGMS - Utang jangka cendhak marang modal Bio Green Med Solution

Simbol lan logo merek Cyclacel Pharmaceuticals (BGMS)

Bio Green Med Solution Inc (BGMS) holds significant authority within the oncology community due to the development of high-precision tools for controlling tumor cell division. The company's revenues rely on partnerships with pharmaceutical behemoths and the commercialization of innovative drugs. The current figure is 0.00. This daily price chart, provided for analytical convenience, complements the profile of a brand renowned for the safety and selectivity of its therapeutic molecules.

Kewajiban jangka cendhak marang modal: Cyclacel Pharmaceuticals (BGMS) kanggo 13.09.2025 - 31.10.2026
Produk mawa merek cyclacel.com

This ratio assesses the dependence of Bio Green Med Solution Inc (BGMS) on liabilities maturing within one year relative to its equity, determining the balance between financial stability and the use of leverage. By analyzing this short-term debt-to-equity chart, an investor can evaluate the liquidity of Bio Green Med Solution Inc (BGMS), which is critical for sustaining costly developments in high-precision targeted oncology therapy.

Pesaing Bio Green Med Solution Inc (BGMS)

Utang jangka cendhak marang ekuitas Genmab US (GMAB)|Exelixis Inc. - Rasio utang jangka cendhak marang modal|Utang jangka cendhak marang modal NUVL (Nuvalent, Inc.)|KYMR - Rasio utang jangka cendhak marang ekuitas|IDYA - Utang jangka cendhak marang ekuitas|Kewajiban jangka cendhak marang modal Enliven Therapeutics Inc|ORIC Pharma (ORIC) - Utang jangka cendhak marang ekuitas|RLAY (Relay Corp) - Utang jangka cendhak marang ekuitas|Utang jangka cendhak marang ekuitas Nurix Therapeutics|Kewajiban jangka cendhak marang modal tyra.bio TYRA|Utang jangka cendhak marang modal VSTM|Monte Rosa Therapeutics Inc (GLUE) - Tanggungan utang jangka cendhak marang ekuitas|Cullinan Therapeutics Inc - Rasio utang jangka cendhak marang ekuitas|Immuneering Corp. (IMRX) - Kewajiban jangka cendhak marang modal|CCCC: Rasio utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal BDTX (blackdiamondtherapeutics.com)|RPTX (Repare Therapeutics Inc.) - Rasio utang jangka cendhak marang ekuitas|PMVP: Rasio silihan jangka cendhak marang modal|KPTI (Karyopharm Therapeutics, Inc.) - Utang jangka cendhak marang modal|Utang jangka cendhak marang modal Propanc Biopharma, Inc.|Utang jangka cendhak marang ekuitas Aadi Bioscience (AADI)|ALRN (aileronrx.com) - Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang modal BPMC (Blueprint Medicines Corporation)|Tanggungan utang jangka cendhak marang ekuitas GlycoMimetics Inc.|SpringWorks - Utang jangka cendhak marang modal